PT782441E - Controlo farmaceutico da inflamacao - Google Patents

Controlo farmaceutico da inflamacao

Info

Publication number: PT782441E
Authority: PT; Portugal
Prior art keywords: control; inflammation; pharmaceutical; oxygenase; inflammation control
Prior art date: 1994-09-22

Application number

PT95932094T

Other languages

English (en)

Inventor

Dean Willis

Adrian Richard Moore

Derek Albert Willoughby

Original Assignee

Negma Lerads

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-22

Filing date

1995-09-22

Publication date

2003-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4154382&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT782441(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-09-22 Application filed by Negma Lerads filed Critical Negma Lerads

2003-07-31 Publication of PT782441E publication Critical patent/PT782441E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Neurology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
Rear-View Mirror Devices That Are Mounted On The Exterior Of The Vehicle (AREA)
Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PT95932094T 1994-09-22 1995-09-22 Controlo farmaceutico da inflamacao PT782441E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002132690A CA2132690A1 (en)	1994-09-22	1994-09-22	Control and modulation of inflammatory response in humans in need of such control and modulation

Publications (1)

Publication Number	Publication Date
PT782441E true PT782441E (pt)	2003-07-31

Family

ID=4154382

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95932094T PT782441E (pt)	1994-09-22	1995-09-22	Controlo farmaceutico da inflamacao

Country Status (12)

Country	Link
EP (1)	EP0782441B1 (pt)
JP (1)	JPH10506388A (pt)
CN (1)	CN1213742C (pt)
AT (1)	ATE233551T1 (pt)
AU (1)	AU3528195A (pt)
CA (1)	CA2132690A1 (pt)
DE (1)	DE69529831T2 (pt)
DK (1)	DK0782441T3 (pt)
ES (1)	ES2192205T3 (pt)
NZ (1)	NZ292963A (pt)
PT (1)	PT782441E (pt)
WO (1)	WO1996009038A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6127356A (en)	1993-10-15	2000-10-03	Duke University	Oxidant scavengers
US5756492A (en) *	1996-09-09	1998-05-26	Sangstat Medical Corporation	Graft survival prolongation with porphyrins
CA2309154C (en)	1997-11-03	2010-02-16	Duke University	Substituted porphyrins
ES2257858T3 (es)	1998-04-24	2006-08-01	Duke University	Porfirinas sustituidas.
JP2003500335A (ja)	1998-12-17	2003-01-07	サングスタットメディカルコーポレイション	ヘムオキシゲナーゼ活性の調節による移植片の生存を強化する方法
EP1616869B1 (en)	1999-01-25	2012-04-04	National Jewish Health	Substituted porphyrins and their therapeutic use
EP1439842A4 (en)	2001-06-01	2009-09-02	Nat Jewish Med & Res Center	OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
CN1646140A (zh)	2002-02-04	2005-07-27	阿尔法玛药品研发有限公司	可释放co的化合物在用于治疗炎症药物的制备中的应用
JP2005522521A (ja) *	2002-04-15	2005-07-28	ベスイスラエルデアコネスメディカルセンター	ヘムオキシゲナーゼ−１およびヘム分解産物の使用法
US7485721B2 (en)	2002-06-07	2009-02-03	Duke University	Substituted porphyrins
FR2842738B1 (fr) *	2002-07-23	2006-02-10	Negma Lerads	Utilisation d'une rheine pour la preparation d'un medicament pour le traitement de l'inflammation chronique, la prevention et le traitement du rejet des transplantations d'organes et de tissus
EP1940425A4 (en) *	2005-09-30	2010-02-03	Ovation Pharmaceuticals Inc	METHOD FOR THE TREATMENT OF PANCREATITIS
US11382895B2 (en)	2008-05-23	2022-07-12	National Jewish Health	Methods for treating injury associated with exposure to an alkylating species
AU2011218316B2 (en) *	2010-02-18	2015-08-20	Vtv Therapeutics Llc	Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
WO2012145520A2 (en)	2011-04-19	2012-10-26	Alfama, Inc.	Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja)	2011-07-21	2017-05-24	アルファーマインコーポレイテッドＡｌｆａｍａ，Ｉｎｃ．	一酸化ルテニウム放出分子およびその使用
CN105727379A (zh) *	2016-02-25	2016-07-06	顾宇春	血红素加氧酶药物洗脱支架
CN110585215B (zh) *	2019-09-19	2023-06-02	中山大学	氯化血红素及其复合物在医药中的新应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5010073A (en) *	1989-10-05	1991-04-23	The Rockefeller University	Use of liposomes as carriers for metalloporphyrins
US5102670A (en) *	1990-09-14	1992-04-07	Abraham Nader G	Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
DE69229598T2 (de) *	1991-04-19	1999-11-04	Childrens Medical Center	Verfahren zur vorbeugung nmda-rezeptorkomplex-vermittelter neuronaler schäden
CA2119572C (en) *	1991-09-24	2005-07-05	Larry Kay Keefer	Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
GB9127376D0 (en) *	1991-12-24	1992-02-19	Wellcome Found	Amidino derivatives
GB9200114D0 (en) *	1992-01-04	1992-02-26	Scras	Dual inhibitors of no synthase and cyclooxygenase
WO1994013252A1 (en) *	1992-12-10	1994-06-23	Hemogen, Inc.	Method for stimulating production of heme oxygenase using vitamin b12

1994
- 1994-09-22 CA CA002132690A patent/CA2132690A1/en not_active Abandoned
1995
- 1995-09-22 ES ES95932094T patent/ES2192205T3/es not_active Expired - Lifetime
- 1995-09-22 CN CNB95196383XA patent/CN1213742C/zh not_active Expired - Fee Related
- 1995-09-22 EP EP95932094A patent/EP0782441B1/en not_active Revoked
- 1995-09-22 JP JP8510696A patent/JPH10506388A/ja not_active Ceased
- 1995-09-22 AT AT95932094T patent/ATE233551T1/de not_active IP Right Cessation
- 1995-09-22 AU AU35281/95A patent/AU3528195A/en not_active Abandoned
- 1995-09-22 WO PCT/GB1995/002249 patent/WO1996009038A2/en not_active Application Discontinuation
- 1995-09-22 NZ NZ292963A patent/NZ292963A/en unknown
- 1995-09-22 DE DE69529831T patent/DE69529831T2/de not_active Revoked
- 1995-09-22 DK DK95932094T patent/DK0782441T3/da active
- 1995-09-22 PT PT95932094T patent/PT782441E/pt unknown

Also Published As

Publication number	Publication date
AU3528195A (en)	1996-04-09
WO1996009038A2 (en)	1996-03-28
CN1213742C (zh)	2005-08-10
NZ292963A (en)	2001-06-29
DK0782441T3 (da)	2003-06-30
CA2132690A1 (en)	1996-03-23
ATE233551T1 (de)	2003-03-15
EP0782441A1 (en)	1997-07-09
CN1166785A (zh)	1997-12-03
ES2192205T3 (es)	2003-10-01
DE69529831D1 (de)	2003-04-10
EP0782441B1 (en)	2003-03-05
DE69529831T2 (de)	2003-12-24
JPH10506388A (ja)	1998-06-23
WO1996009038A3 (en)	1996-06-13

Publication	Publication Date	Title
PT782441E (pt)	2003-07-31	Controlo farmaceutico da inflamacao
DE69739656D1 (de)	2009-12-31	1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
ATE135231T1 (de)	1996-03-15	Verwendung von ''cartilage-inducing factor'' (cif) zur behandlung von hemato- oder lymphopoietischen krankheiten
CA2105529A1 (en)	1994-03-05	Composition comprising non-steroidal anti-inflammatory agent and effectively non-antibacterial tetracycline
MX9308199A (es)	1995-01-31	Inhibidores de enzima.
ATE31243T1 (de)	1987-12-15	Verwendung von 4-aminosalicylsaeure als entzuendungshemmender wirkstoff.
CA2262847A1 (en)	1998-02-12	Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
NO20002440D0 (no)	2000-05-11	Hydroksam- og karboksylsyrederivater med MMP- og TNF- inhiberende aktivitet
ES2138940T1 (es)	2000-02-01	Quelactantes de plata del acido etilendiamintriacetico y del acido n-acil etilendiamintriacetico.
DE69620458D1 (de)	2002-05-08	Benzofuran-carboxamide und -sulfonamide
DE69609864T2 (de)	2001-01-04	Steroidnitritesterderivate und ihre verwendung als entzündungshemmende medikamente
DE69727583D1 (de)	2004-03-18	Vermeidung von gastrointestinaler schädigung
ES2161293T3 (es)	2001-12-01	Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
HUP9902417A2 (hu)	1999-11-29	Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
DK0673646T3 (da)	1999-08-16	Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
CA2149766A1 (en)	1994-06-09	Rectal flunisolide compositions for treating inflammatory intestinal disorders
NO901920D0 (no)	1990-04-27	Nye polypeptidforbindelser.
ATE232849T1 (de)	2003-03-15	4-phenyl-3-substituierte 1,4-dihydropyridinester mit cerebraler aktivität
RU94041246A (ru)	1996-10-10	Способ лечения псориаза
DK1017377T3 (da)	2002-03-04	Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
FR2690344B1 (fr)	1994-07-01	Compositions therapeutiques a dosage topique dans le traitement effectif de la psoriasis.
IT8819447A0 (it)	1988-02-17	Composizione di composti che migliorano l'attivita' analgesica, antipiretica e antinfiammatoria.
UA19222A (uk)	1997-12-25	Спосіб лікуваhhя стеhокардії
RO86650B1 (ro)	1985-03-03	Preparat farmaceutic pentru tratarea dermatozelor
MY105242A (en)	1994-08-30	Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles.